France’s second wave of coronavirus could be worse than the first, the boss of Paris public hospital group AP-HP said on Friday as the country registered a record number of daily cases.
With fast-rising pressure on hospitals, France has expanded a 9:00 pm to 06:00 am curfew to cover 46 million people, more than two-thirds of its population.
“There has been a perception in recent months that a second wave does not exist, or that it is a small wave. The situation is the opposite,” Martin Hirsch told the RTL broadcaster.
“It is possible that the second wave will be worse than the first,” he said, warning of a “daunting” challenge ahead.
On Thursday, France reported a daily record of 41,622 new cases, and the number of patients in intensive care is at its highest level since May.
Thursday’s figure of 165 fatalities in 24 hours is still well below the April peak, when the death toll soared to more than 900 a day.
‘November will be difficult’
Prime Minister Jean Castex conceded that hospitals were likely to come under pressure.
“The new cases of today are the hospitalised patients of tomorrow. The month of November will be difficult,” he wrote on Twitter.
Hirsch said the average age of intensive care patients in AP-HP’s hospitals was 62.
Many were older people who self-isolated but were infected when their children visited them.
And Hirsch said the real number of cases was likely to be much higher than official tallies, as many asymptomatic carriers are never tested.
“There are many positive people, infectious, in the streets without knowing it and without anyone else knowing it,” he said.
Hirsch said the leave of some hospital workers had been cancelled ahead of “this daunting month of November”.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2020 AFP
Second virus wave could be worst than first: France hospital boss (2020, October 23)
retrieved 23 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022